Paper35911136
High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.
Bao Z and 8 others. Evid Based Complement Alternat Med, 2022. Cited by 1 paper, by iCite. Retracted.
Cite this record
ConductScience Library. High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. Papers, record 35911136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35911136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 37387918 | Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. | https://conductscience.org/library/papers/37387918 |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34587888 | Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. | Recent Pat Anticancer Drug Discov | 2022 | https://conductscience.org/library/papers/34587888 | PubMed |
| 2 | 34998526 | [New drug approval: Pembrolizumab in association with chemotherapy as first line treatment for advanced/metastatic oesophageal carcinomas or HERnegative gastroesophageal adenocarcinoma, expressing PD-L1 with a CPS≥10]. | Bull Cancer | 2022 | https://conductscience.org/library/papers/34998526 | PubMed |
| 3 | 27892511 | The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients. | Sci Rep | 2016 | https://conductscience.org/library/papers/27892511 | PubMed |
| 4 | 25292338 | Histone chaperone CAF-1: essential roles in multi-cellular organism development. | Cell Mol Life Sci | 2015 | https://conductscience.org/library/papers/25292338 | PubMed |
| 5 | 33159034 | PD-L1 degradation pathway and immunotherapy for cancer. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/33159034 | PubMed |
| 6 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 7 | 30449701 | CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression. | EBioMedicine | 2018 | https://conductscience.org/library/papers/30449701 | PubMed |
| 8 | 33009508 | The changing face of gastric cancer: epidemiologic trends and advances in novel therapies. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/33009508 | PubMed |
| 9 | 28796808 | PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/28796808 | PubMed |
| 10 | 33277876 | CHAF1A overexpression in human retinoblastoma promotes cell proliferation and suppresses apoptosis. | J BUON | 2020 | https://conductscience.org/library/papers/33277876 | PubMed |
| 11 | 21282622 | CAF-I-dependent control of degradation of the discontinuous strands during mismatch repair. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21282622 | PubMed |
| 12 | 24845563 | Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer. | Biochem Biophys Res Commun | 2014 | https://conductscience.org/library/papers/24845563 | PubMed |
| 13 | 25057015 | A separable domain of the p150 subunit of human chromatin assembly factor-1 promotes protein and chromosome associations with nucleoli. | Mol Biol Cell | 2014 | https://conductscience.org/library/papers/25057015 | PubMed |
| 14 | 31933995 | PD-L1 expression in colon cancer and its relationship with clinical prognosis. | Int J Clin Exp Pathol | 2019 | https://conductscience.org/library/papers/31933995 | PubMed |
| 15 | 33616161 | Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer. | Biosci Rep | 2021 | https://conductscience.org/library/papers/33616161 | PubMed |
| 16 | 28286267 | Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28286267 | PubMed |
| 17 | 35130500 | Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 | https://conductscience.org/library/papers/35130500 | PubMed |
| 18 | 34365742 | CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34365742 | PubMed |
| 19 | 23810557 | Subunits of the histone chaperone CAF1 also mediate assembly of protamine-based chromatin. | Cell Rep | 2013 | https://conductscience.org/library/papers/23810557 | PubMed |
| 20 | 30264329 | EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions. | Gastric Cancer | 2019 | https://conductscience.org/library/papers/30264329 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 37387918 | Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer. | Evid Based Complement Alternat Med | 2023 | https://conductscience.org/library/papers/37387918 |
Source PubMed
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35911136
GET https://conductscience.org/api/papers/v1/35911136/references?page=2